Compass Financial Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,653
Closed -$387K 128
2022
Q2
$387K Sell
2,653
-600
-18% -$87.5K 0.53% 68
2022
Q1
$386K Sell
3,253
-652
-17% -$77.4K 0.43% 84
2021
Q4
$538K Buy
+3,905
New +$538K 0.59% 65